Phentermine for weight loss: doses, uses, and side effects
Reviewed by Felix Gussone, MD, Ro,
Written by Ellyn Vohnoutka, BSN, RN
Reviewed by Felix Gussone, MD, Ro,
Written by Ellyn Vohnoutka, BSN, RN
last updated: Jul 01, 2024
4 min read
Here's what we'll cover
Obesity is a significant and growing public health challenge in the United States. In fact, the prevalence of obesity has nearly doubled since 1980. It’s estimated that 51% of U.S. adults will have obesity by 2030. While healthy eating and regular exercise are key to weight loss, some medications–like phentermine–can help you lose weight and keep weight off.
Combined with a healthy diet and exercise, phentermine can act as an appetite suppressant to promote and maintain weight loss. However, since the medication is a stimulant, it should be used with caution.
Continue reading to learn more about phentermine for weight loss, doses, and potential side effects.
What is phentermine?
Phentermine, also known as Lomaira and Adipex-P, is meant to be used short-term, and in combination with a reduced-calorie diet and exercise program.
This medication is approved for use by individuals with a starting body mass index (BMI) greater than 30 or greater than 27 for those with an obesity-related health condition, such as:
Uncontrolled high blood pressure
Elevated cholesterol levels
Phentermine is also frequently found in combination medications with other drugs to help stimulate weight loss. The U.S. Food and Drug Administration (FDA) approved the combination of phentermine and topiramate (Qsymia) in 2012 to treat obesity. Topiramate is an anti-seizure medicine that also works as an appetite suppressant.
Does phentermine help you lose weight?
Phentermine is effective for promoting weight loss. In fact, a randomized controlled trial over 12 weeks looked at the safety and efficacy of phentermine in participants with controlled diabetes, high blood pressure, or elevated cholesterol. The trial found that participants who received phentermine lost more weight than the placebo and had lower cholesterol levels.
Some research has shown that those who take a daily dose of 15 mg may see weight loss of up to 7% of their initial body weight after six months.
While phentermine is only FDA-approved for short-term use (12 weeks), many healthcare providers prescribe the medication off-label for more long-term use. Or, your healthcare provider may prescribe phentermine intermittently, which means you take a break from the medication before returning to it.
Unfortunately, not everyone will have success using phentermine. If you haven’t seen adequate results after 3 months of use, your healthcare provider may want to explore other treatment options.
How does phentermine for weight loss work?
Phentermine works as an appetite suppressant. The medication is a stimulant and works in the same way as amphetamines–by stimulating the release of the neurotransmitters norepinephrine and epinephrine (the hormones behind your “flight or fight” response) in your brain.
When phentermine stimulates these neurotransmitters, it reduces your appetite, making you feel full sooner. It’s often prescribed to be taken alone, but phentermine is also available in combination with other weight-loss medications.
Phentermine should be used with caution. The Federal Drug Enforcement Administration (DEA) classifies phentermine as a schedule IV controlled substance, meaning it has the potential for abuse and dependence. This is due to its similarities to amphetamines, but phentermine is considered a lower-risk drug than amphetamines.
Most of the concerns for abuse or addiction with phentermine have not been supported by the research. People who suddenly stop taking phentermine are not known to experience withdrawal symptoms.
How do you take phentermine?
Phentermine is a pill you take by mouth once daily, either before breakfast or up to two hours afterward. As mentioned, it is only FDA-approved for short-term use (12 weeks), but some healthcare providers may prescribe it off-label for long-term use.
The longest trial conducted with phentermine was a 36-week trial that took place in 1968. It looked at continuous and intermittent use of phentermine compared to a placebo. Both ways of taking phentermine were found to be safe and resulted in more significant weight loss than the study participants taking a placebo.
Phentermine dose
Phentermine is available in doses of 15, 30, or 37.5 milligrams. One common technique used by some healthcare providers is to prescribe the generic 37.5 mg tablet and instruct the user to take half a tablet (18.75 mg) each morning.
Side effects of phentermine
Since phentermine is chemically similar to amphetamines, they share many of the same potential side effects. Some common side effects from phentermine include:
Heart palpitations
Elevated heart rate
High blood pressure
Nervousness
Dry mouth
Headache
Sweating
Constipation
Thirst
These effects tend to be worse right when you start taking the medication and decrease with continued use.
Rare side effects that may occur with phentermine include:
Atrial fibrillation (an irregular heartbeat)
Sudden psychosis
Pulmonary hypertension
Phentermine for treating eating disorders
The combination of phentermine and topiramate may help reduce binge eating in people with binge eating disorders (BED) and bulimia nervosa.
One small, preliminary 12-week study of people with binge eating disorders who were overweight found that participants who took both phentermine and topiramate had reductions in binge-eating episodes.
Who shouldn’t take phentermine?
Not all medications are suitable for everybody. Your healthcare provider can help you determine if phentermine might be helpful in your weight loss efforts.
People with heart disease should use extreme caution when using phentermine because it can cause increased blood pressure and an elevated heart rate.
If you have any of the following risk factors or conditions, you should not use phentermine:
Hyperthyroidism (an overactive thyroid)
Glaucoma
Agitation
A history of drug abuse
Current pregnancy
Breastfeeding
Currently using a class of antidepressants called monoamine oxidase inhibitors (MAOIs)
People with a history of psychiatric or cognitive disorders should be cautious when using phentermine. Symptoms including anxiety, depression, or insomnia can occur. If you have a history of a mood disorder, these symptoms can come back when you use phentermine. Your provider should monitor you carefully for changes in your mood and behavior.
Where to buy phentermine for weight loss
Phentermine for weight loss is only available by prescription. If you think you may need some additional help with losing weight on top of diet and exercise, make an appointment with your healthcare provider to see if phentermine or another option is right for you. Make sure to tell your provider if you are taking any other medications or supplements to prevent drug interactions.
While many people do lose weight while taking phentermine, it can take several months. Your provider can help you set realistic expectations for your anticipated results.
If you’re struggling with weight loss, you’re not alone. Make an appointment to create a treatment plan that will be safe and effective for you.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Apovian, C. M., Aronne, L. J., Bessesen, D. H., et al. (2015). Pharmacological management of obesity: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 100(2), 342-362. doi: 10.1210/jc.2014-3415. Retrieved from https://academic.oup.com/jcem/article/100/2/342/2813109
Bersoux, S., Byun, T. H., Chaliki, S. S., & Poole, K. G. (2017). Pharmacotherapy for obesity: what you need to know. Cleveland Clinic Journal Of Medicine, 84(12), 951–958. doi: 10.3949/ccjm.84a.16094. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29244650/
Danaei, G., Finucane, M. M., Lin, J. K., et al. (2011). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet (London, England), 377(9765), 568–577. https://doi.org/10.1016/S0140-6736(10)62036-3. Retrieved from https://pubmed.ncbi.nlm.nih.gov/21295844/
Guerdjikova, A. I., Williams, S., Blom, T. J., et al. (2018). Combination Phentermine-Topiramate Extended Release for the Treatment of Binge Eating Disorder. Innovations In Clinical Neuroscience, 15(5-6), 17-21. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040720/
Johnson, D. B. & Quick, J. (2021). Topiramate and phentermine. StatPearls. Retrieved on Oct. 11, 2021 from https://www.ncbi.nlm.nih.gov/books/NBK482165/
Kang, J. G., Park, C. Y., Kang, J. H., et al. (2010). Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. Diabetes, Obesity & Metabolism, 12(10), 876–882. doi10.1111/j.1463-1326.2010.01242.x. Retrieved from https://pubmed.ncbi.nlm.nih.gov/20920040/
Narayanaswami, V. & Dwoskin, L. P. (2017). Obesity: current and potential pharmacotherapeutics and targets. Pharmacology & Therapeutics, 170, 116–147. doi: 10.1016/j.pharmthera.2016.10.015. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274590/
National Center for Biotechnology Information. (2024). PubChem Compound Summary for CID 4771, Phentermine. Retrieved Jun. 21, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Phentermine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2020). Phentermine. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Retrieved on Oct. 11, 2021 from https://www.ncbi.nlm.nih.gov/books/NBK547916/
Sombra, L. R. S. & Anastasopoulou, C. (2021). Pharmacologic therapy for obesity. StatPearls. Retrieved on Oct. 11, 2021 from https://www.ncbi.nlm.nih.gov/books/NBK562269/
Tirthani, E. & Quartuccio, M. (2021). Non-dieting approaches to treatment of obesity. StatPearls. Retrieved on Oct. 11, 2021 from https://www.ncbi.nlm.nih.gov/books/NBK572129/
Yanovski, S. Z. & Yanovski, J. A. (2014). Long-term drug treatment for obesity: a systematic and clinical review. JAMA, 311(1), 74–86. https://doi.org/10.1001/jama.2013.281361. Retrieved from https://jamanetwork.com/journals/jama/fullarticle/1774038